R&A PSYINS, our psychedelic insurance division, released its Psychedelic Medicine Year-End Analysis and 2024 Outlook: “Navigating the Opportunities, Challenges and Unique Risks of Providing Breakthrough Treatments.”
Produced in partnership with Neuly and Psychedelic Invest, the report discusses the catalysts that could propel the industry forward, emerging opportunities and challenges, and the specific Business Liability insurances that will be important for psychedelic businesses and practitioners to secure in 2024.
To access the report, click here. If you have questions regarding psychedelic business insurance or would like a detailed risk assessment and analysis, please contact Eric Rahn for a consultation at (954) 790-6604 or email email@example.com.
About R&A PSYINS
R&A PSYINS is a division of Rahn & Associates, an independent insurance broker that provides specialty lines of insurance coverages for highly regulated and complex industries, such as psychedelic medicine. Our extensive network and long-standing relationships with industry-leading insurance companies enables us to provide licensed therapists and clinicians, Ketamine clinics, drug and product developers, mushroom cultivators, early and late-stage research and development, wellness retreats, as well as private equity and investors in the psychedelic sector, with Business Liability insurance coverages. For more information, visit https://www.psy-ins.com/.